0

Rosiglitazone - CAS 155141-29-0

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP155141290
CAS155141-29-0
Structure
DescriptionA thiazolidinedione compound that acts as an anti-diabetic agent and serves as a potent and selective agonist of peroxisome proliferator-activated receptor-γ (PPARγ) (Kd ~40 nM) in fat cells.
SolubilityDMSO: 100 mg/mL
Assay≥99% (HPLC)
Colorwhite
Formpowder; protect from light
Size10MG
Storage Conditions-20C
1

[Drug Interactions--Their Impact on Safe Drug Therapy in the Example of the New Thiazolidinedione Group (Glitazone)]

U Klotz, D Sailer

Arzneimittelforschung. 2001 Feb;51(2):112-7.

PMID: 11258040

1

HPLC Method for the Determination of Rosiglitazone in Human Plasma and Its Application in a Clinical Pharmacokinetic Study

Rao N V S Mamidi, Madhusudana R Chaluvadi, Biju Benjamin, Mullangi Ramesh, Kasiram Katneni, Aravinda P Babu, Jaydip Bhanduri, Naidu M U Rao, Ramanujam Rajagopalan

Arzneimittelforschung. 2002;52(7):560-4.

PMID: 12189780

1

Prevention of Sodium Valproate-Induced Hepatotoxicity by Curcumin, Rosiglitazone and N-acetylcysteine in Rats

Shehta Abd-Allah Said, Dina Saad El-Agamy

Arzneimittelforschung. 2010;60(11):647-53.

PMID: 21175036

1

Studies on the Euglycemic and Hypolipidemic Potentials of the Novel Indole Analogue of Thiazolidinedione, DRF 2189

R Chakrabarti, R K Vikramadithyan, T Dileepkumar, K B Kumar, M P Kumar, P Misra, P B Rao, V B Lohray, B B Lohray, R Rajagopalan

Arzneimittelforschung. 1999 Nov;49(11):905-11.

PMID: 10604043

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode